Outcomes of Unselected Recipients of Sirolimus-Eluting Stents: The Cypher® Stent U.S. Post-Marketing Surveillance Registry

by CLT Staff on February 2, 2010

ABSTRACT: Objective. To examine the 1-year safety and clinical outcomes associated with the post-marketing early unselected use of sirolimus-eluting stents (SES) in the United States

See the original post here:
Outcomes of Unselected Recipients of Sirolimus-Eluting Stents: The Cypher® Stent U.S. Post-Marketing Surveillance Registry
 

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.

Leave a Comment

Previous post:

Next post: